Long-term safety and efficacy of long-ac
β
Werner Kissling; Per Glue; Rossella Medori; Steve Simpson
π
Article
π
2007
π
John Wiley and Sons
π
English
β 144 KB
π 1 views
## Abstract This subgroup analysis of the 6βmonth, openβlabel Switch to Risperidone Microspheres (StoRMi) trial evaluated longβterm safety and efficacy of a direct conversion to risperidone longβacting injectable (RLAI) in 52 elderly patients (β₯65 years) with psychosis stabilized on oral or depot a